Revenue
No reported data
OS Therapies Inc (OSTX)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research & development | $16.4M | $2.8M | $3.2M |
| Operating income | −$28.7M | −$6.8M | −$4.3M |
| EBITDAderived | −$28.3M | −$6.8M | — |
| Net income | −$28.8M | −$8.9M | −$7.8M |
| Basic EPSper diluted share | -$0.98 | -$1.28 | -$1.46 |
| Diluted EPSper diluted share | -$0.98 | -$1.28 | -$1.46 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 7, 2025Form 4 | Auerbach Shalom +1TenPercentOwner | SellCommon Stock, par value $0.001 per share · indirect | 82.0K | $2.00 | $164.0K | 2.66M |
| Apr 10, 2025Form 4 | Auerbach Shalom +1TenPercentOwner | SellCommon Stock, par value $0.001 per share · indirect | 10.0K | $1.39 | $13.9K | 2.75M |
| Apr 9, 2025Form 4 | Auerbach Shalom +1TenPercentOwner | SellCommon Stock, par value $0.001 per share · indirect | 50.0K | $1.35 | $67.5K | 2.76M |
| Feb 14, 2025Form 4 | Einodmil LLC +1TenPercentOwner | SellCommon Stock, par value $0.001 per share · indirect | 100.0K | $2.84 | $284.0K | 2.43M |
| Jan 15, 2025Form 4 | Auerbach Shalom +1TenPercentOwner | SellCommon Stock, par value $0.001 per share · indirect | 16.7K | $6.74 | $112.7K | 2.53M |